Percutaneous Mechanical Circulatory Support in Post-Myocardial Infarction Cardiogenic Shock: A Systematic Review and...

Area of Science:

• Cardiology
• Interventional Cardiology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), leading to high early mortality.
• The role of percutaneous mechanical support (pMCS) devices in improving outcomes for AMI-complicated CS remains uncertain.

Purpose of the Study:

• To systematically review and analyze the existing evidence on the effectiveness of pMCS devices in reducing mortality in patients with AMI-complicated CS.

Main Methods:

• A systematic review and meta-analysis were conducted using data from Medline, Embase, Google Scholar, and the Cochrane Library.
• Fifty relevant studies were included in the quantitative analysis, with additional references sourced elsewhere.

Main Results:

• Intra-aortic balloon pump (IABP) showed a significant mortality reduction in specific subgroups (failed primary percutaneous coronary intervention or thrombolysis).
• Impella did not demonstrate an advantage over conventional therapy and showed increased mortality compared to IABP.
• Extracorporeal membrane oxygenation (ECMO) did not show a mortality advantage, but adding IABP or Impella to ECMO might improve early mortality.
• All pMCS strategies were associated with an increased risk of severe bleeding (Bleeding Academic Research Consortium ≥ 3).

Conclusions:

• The current evidence supporting pMCS in AMI-CS is of poor to moderate quality, with limited randomized data.
• IABP may be beneficial in selected patients with AMI-CS, particularly those treated with thrombolysis or failed primary percutaneous coronary intervention.
• Consideration should be given to adding IABP or Impella for patients requiring ECMO support for CS.
• Increased bleeding risk is a significant concern with all pMCS strategies.